Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Marimed (MRMD) Receivables - Other (2016 - 2024)

Marimed has reported Receivables - Other over the past 12 years, most recently at $302000.0 for Q3 2024.

  • Quarterly Receivables - Other rose 247.13% to $302000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $302000.0 through Sep 2024, up 247.13% year-over-year, with the annual reading at $105000.0 for FY2023, 262.07% up from the prior year.
  • Receivables - Other was $302000.0 for Q3 2024 at Marimed, up from $233000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $29.0 million in Q4 2020 and troughed at $29000.0 in Q4 2022.
  • The 5-year median for Receivables - Other is $215840.0 (2020), against an average of $3.2 million.
  • Year-over-year, Receivables - Other tumbled 99.42% in 2022 and then skyrocketed 565.71% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $29.0 million in 2020, then plummeted by 82.76% to $5.0 million in 2021, then tumbled by 99.42% to $29000.0 in 2022, then surged by 262.07% to $105000.0 in 2023, then skyrocketed by 187.62% to $302000.0 in 2024.
  • Per Business Quant, the three most recent readings for MRMD's Receivables - Other are $302000.0 (Q3 2024), $233000.0 (Q2 2024), and $181000.0 (Q1 2024).